Related Experiment Videos
Myocyte death in heart failure
P Anversa1, J Kajstura, G Olivetti
1New York Medical College, Department of Medicine, Valhalla 10595, USA.
Insights
Decompensated eccentric ventricular hypertrophy leads to heart failure, with myocyte loss driving cardiac dysfunction. Apoptosis significantly contributes to myocyte death in ischemic heart disease, but the role of fibrosis remains unclear.
Area of Science:
- Cardiovascular Medicine
- Cardiac Pathophysiology
- Myocardial Remodeling
Background:
- Decompensated eccentric ventricular hypertrophy signifies the progression from compensated overload to heart failure.
- Myocyte loss, through apoptosis or necrosis, is a key factor in cardiac myopathy development.
- Apoptotic cell death is more prevalent than necrosis in ischemic heart disease.
Purpose of the Study:
- To investigate the role of myocyte loss in cardiac myopathy progression.
- To understand the mechanisms of myocyte death (apoptosis vs. necrosis) in heart failure.
- To determine if reactive fibrosis initiates or secondary to myocyte death.
Main Methods:
- Analysis of cardiac tissue from patients with heart failure.
- Histological examination to assess myocyte death and fibrosis.
- Comparison of apoptotic and necrotic cell death markers.
Main Results:
- Myocyte loss is a primary driver of ventricular wall thinning and chamber dilation.
- Apoptosis is the predominant mode of myocyte death in ischemic cardiomyopathy.
- The precise role of reactive fibrosis in initiating ventricular dysfunction requires further elucidation.
Conclusions:
- Myocyte loss is central to the progression of cardiac myopathy.
- Apoptosis plays a critical role in the pathogenesis of ischemic heart failure.
- The relationship between fibrosis and myocyte death in heart failure warrants further investigation.
Abstract:
Decompensated eccentric ventricular hypertrophy characterizes the transition from compensated pressure or volume over-load hypertrophy to myocardial dysfunction and failure. Myocyte loss is the major etiologic factor of wall thinning and chamber dilation and may condition the progression of the cardiac myopathy. Myocyte death can occur by apoptosis or necrosis, but the activation of the suicide program of myocytes exceeds necrotic cell death in the pathologic heart of ischemic origin. Whether reactive fibrosis constitutes a primary event in the initiation of ventricular dysfunction or a secondary reaction to myocyte death is an important unanswered question.